That only looks at three cancers. The oncology literature tracks survival rates across all cancer incidence, in which the US consistently comes out on top. Only a few other countries, such as Switzerland, are close.

It is attributable almost entirely to more aggressive (and expensive) diagnostics combined with many new cancer therapies being available in the US years before they trickle down to the rest of the world.